Generali Investments Towarzystwo Funduszy Inwestycyjnych Amgen Inc Transaction History

Generali Investments Towarzystwo Funduszy Inwestycyjnych

$157 Billion
Q1 2025

A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Amgen Inc stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 2,500 shares of AMGN stock, worth $696,000. This represents 0.49% of its overall portfolio holdings.

Number of Shares

2,500

Previous 2,500 -0.0%

Holding current value

$696,000

Previous $652 Million 19.53%

% of portfolio

0.49%

Previous 0.38%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$258.78 - $328.31 $51,755 - $65,662	200 Added 8.7%	2,500 $652 Million
Q2 2024 Feb 05, 2025	SELL	$262.75 - $319.31 $52,550 - $63,862	-200 Reduced 8.0%	2,300 $719 Million
Q3 2023 Feb 05, 2025	BUY	$218.65 - $271.46 $65,595 - $81,438	300 Added 13.64%	2,500 $720 Million
Q2 2023 Feb 05, 2025	BUY	$214.27 - $253.37 $64,281 - $76,011	300 Added 15.79%	2,200 $488 Million
Q1 2023 Feb 05, 2025	BUY	$225.79 - $275.2 $67,737 - $82,560	300 Added 18.75%	1,900 $459 Million
Q4 2022 Feb 05, 2025	SELL	$229.03 - $291.01 $34,354 - $43,651	-150 Reduced 8.57%	1,600 $420 Million
Q3 2022 Feb 05, 2025	SELL	$224.46 - $253.15 $67,338 - $75,945	-300 Reduced 14.63%	1,750 $394 Million
Q2 2022 Feb 05, 2025	SELL	$230.71 - $256.74 $103,819 - $115,533	-450 Reduced 18.0%	2,050 $499 Million
Q1 2022 Feb 05, 2025	BUY	$219.27 - $242.57 $548,175 - $606,425	2,500 New	2,500 $605 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Investments Towarzystwo Funduszy Inwestycyjnych, based on Form 13F filings with the SEC.

News

Stay updated on Generali Investments Towarzystwo Funduszy Inwestycyjnych with notifications on news.

Account

Generali Investments Towarzystwo Funduszy Inwestycyjnych Amgen Inc Transaction History